Wespac Advisors, LLC Abb Vie Inc. Transaction History

Wespac Advisors, LLC

$131 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $79,218 - $91,707	593 Added 4.89%	12,720 $1.9 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $81,361 - $101,248	-614 Reduced 4.82%	12,127 $1.63 Million
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $1.84 Million - $2.12 Million	12,741 New	12,741 $2.03 Million
Q3 2022 Oct 18, 2022	SELL	$134.21 - $153.93 $716,815 - $822,140	-5,341 Reduced 31.3%	11,722 $1.57 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $1.06 Million - $1.35 Million	7,690 Added 82.04%	17,063 $2.61 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $688,935 - $854,775	-5,220 Reduced 35.77%	9,373 $1.52 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $16,759 - $21,205	156 Added 1.08%	14,593 $1.98 Million
Q3 2021 Oct 14, 2021	BUY	$106.4 - $120.78 $878,438 - $997,159	8,256 Added 133.57%	14,437 $1.56 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $750,568 - $836,176	-7,134 Reduced 53.58%	6,181 $696,000
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $393,343 - $433,023	-3,845 Reduced 22.41%	13,315 $1.44 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $1.38 Million - $1.86 Million	17,160 New	17,160 $1.84 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $1 Million - $1.52 Million	-15,555 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $131,709 - $164,796	-1,826 Reduced 10.51%	15,555 $1.38 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $663,305 - $797,483	-10,532 Reduced 37.73%	17,381 $1.32 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $1.83 Million - $2.34 Million	27,913 New	27,913 $2.03 Million
Q1 2019 Apr 19, 2019	SELL	$77.14 - $90.79 $2.48 Million - $2.92 Million	-32,170 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $2.5 Million - $3.09 Million	32,170 New	32,170 $2.97 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $1.7 Million - $2.28 Million	-18,466 Closed	0 $0
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $105,501 - $115,691	-1,178 Reduced 6.0%	18,466 $1.79 Million
Q3 2017 Oct 24, 2017	SELL	$69.85 - $89.22 $88,290 - $112,774	-1,264 Reduced 6.05%	19,644 $1.75 Million
Q2 2017 Aug 10, 2017	BUY	N/A	20,908	20,908 $1.52 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors, LLC with notifications on news.

Account